Lung transplantation can improve survival in patients with chronic obstructive pulmonary disease, but several variables can affect the surgery's success.
A new cystic fibrosis transmembrane conductance regulator modulator treatment has been approved by the FDA for use in patients aged 12 years and older.
Maternal prenatal and early childhood intake of sugar-sweetened beverages and fructose is associated with current asthma in midchildhood.
CFTR modulator therapy recommended in certain patients with cystic fibrosis.
Researchers conducted an anonymous survey of medical trainees with a case vignette to determine attitudes regarding palliative care for chronic obstructive pulmonary disease.
Researchers compared the clinical cure and adverse effect rates of multiple antibiotics in the treatment of acute exacerbations in chronic obstructive pulmonary disease.
High levels of C-reactive protein and neutrophils as well as low eosinophil count predicted a poor prognosis in COPD.
Respiratory symptoms that develop between the ages of 18 and 30 may hold prognostic value for later decline in lung function.
Researchers examined variation in airway branches to determine whether they have an effect on the course of chronic obstructive pulmonary disease.
Patients with COPD experienced a weighted mean increase in exercise endurance time following treatment with long-acting bronchodilators.
Children who received oral prednisolone vs placebo for virus-associated wheeze had a shorter length of hospital stay.
Prednisolone may be a more effective treatment in individuals with acute allergic bronchopulmonary aspergillosis complicated asthma, but with more adverse effects compared with itraconazole.
Researchers found that tiotropium was safe and may reduce the risk for exacerbations in young children with asthma.
Lung function may not differ between individuals who take beta-blockers vs those who do not for moderate to severe chronic obstructive pulmonary disease.
COPD exacerbation risk and treatment response may be predicted using blood eosinophil counts.
A 55-year-old man with asthma presents to the emergency department with dyspnea at rest and electrocardiogram findings suggest a prior myocardial infarction.
Procalcitonin may decrease mortality rates in patients with acute respiratory infections, including pneumonia.
Although the 2017 GOLD classification did not better predict mortality in patients with chronic obstructive pulmonary disease overall, it did so when patients were extensively categorized by severity.
No data have demonstrated improved mortality, morbidity, or quality of life as a result of screening for COPD in asymptomatic individuals.
Timing of birth may increase risk for asthma or atopic dermatitis.